MarketBeat Instant News Alerts 2 hours agoNEXT (LON:NXT) Insider Jeni Mundy Acquires 160 SharesMarketBeatNEXT plc (LON:NXT - Get Free Report) insider Jeni Mundy purchased 160 shares of the firm's stock in a transaction on Tuesday, August 11th. The shares were acquired at an average cost of £155.45 per share, with a total value of £24,872. LON:NXTRead NEXT (LON:NXT) Insider Jeni Mundy Acquires 160 Shares2 hours agoBTIG Research Reaffirms Buy Rating for Mobia Medical (NASDAQ:MOBI)MarketBeatBTIG Research restated a "buy" rating and issued a $19.00 price objective on shares of Mobia Medical in a research note on Wednesday.NASDAQ:MOBIRead BTIG Research Reaffirms Buy Rating for Mobia Medical (NASDAQ:MOBI)2 hours agoMaze Therapeutics (NASDAQ:MAZE) Earns "Buy" Rating from BTIG ResearchMarketBeatBTIG Research reissued a "buy" rating and set a $46.00 target price on shares of Maze Therapeutics in a research note on Wednesday.NASDAQ:MAZERead Maze Therapeutics (NASDAQ:MAZE) Earns "Buy" Rating from BTIG Research2 hours agoPiper Sandler Initiates Coverage on LightPath Technologies (NASDAQ:LPTH)MarketBeatPiper Sandler started coverage on LightPath Technologies in a research note on Wednesday. They set an "overweight" rating and a $15.00 target price for the company.NASDAQ:LPTHRead Piper Sandler Initiates Coverage on LightPath Technologies (NASDAQ:LPTH)2 hours agoIntuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at OppenheimerMarketBeatOppenheimer raised Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price target on the stock in a research note on Wednesday.NASDAQ:ISRGRead Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at Oppenheimer2 hours agoBTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock PriceMarketBeatBTIG Research upped their target price on shares of Innate Pharma from $8.00 to $9.00 and gave the stock a "buy" rating in a research note on Wednesday.NASDAQ:IPHARead BTIG Research Issues Positive Forecast for Innate Pharma (NASDAQ:IPHA) Stock Price Trending News1Bank of America Corp DE Purchases 7,079,903 Shares of NIO Inc. $NIO2Super Micro Computer, Inc. $SMCI Shares Bought by Quantinno Capital Management LP3Bank of New York Mellon Corp Acquires 221,957 Shares of SELLAS Life Sciences Group, Inc. $SLS4Janus Henderson Group PLC Takes Position in Rezolve AI PLC $RZLV5Brokers Issue Forecasts for Datavault AI FY2026 Earnings6California State Teachers Retirement System Acquires 488,883 Shares of Plug Power, Inc. $PLUG7Alphabet (NASDAQ:GOOGL) Stock Price Down 3.8% - Time to Sell?8SpaceX (NASDAQ:SPCX) Shares Up 4.2% Following Analyst Upgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoHovde Group Forecasts Strong Price Appreciation for HBT Financial (NASDAQ:HBT) StockMarketBeatNASDAQ:HBTRead Hovde Group Forecasts Strong Price Appreciation for HBT Financial (NASDAQ:HBT) Stock2 hours agoBTIG Research Reaffirms Buy Rating for Gain Therapeutics (NASDAQ:GANX)MarketBeatNASDAQ:GANXRead BTIG Research Reaffirms Buy Rating for Gain Therapeutics (NASDAQ:GANX)2 hours agoCantor Fitzgerald Reaffirms "Overweight" Rating for Firefly Aerospace (NASDAQ:FLY)MarketBeatNASDAQ:FLYRead Cantor Fitzgerald Reaffirms "Overweight" Rating for Firefly Aerospace (NASDAQ:FLY)2 hours agoeToro Group (NASDAQ:ETOR) Price Target Cut to $53.00 by Analysts at Needham & Company LLCMarketBeatNASDAQ:ETORRead eToro Group (NASDAQ:ETOR) Price Target Cut to $53.00 by Analysts at Needham & Company LLC2 hours agoCantor Fitzgerald Has Lowered Expectations for eToro Group (NASDAQ:ETOR) Stock PriceMarketBeatNASDAQ:ETORRead Cantor Fitzgerald Has Lowered Expectations for eToro Group (NASDAQ:ETOR) Stock Price2 hours agoErasca (NASDAQ:ERAS) Given New $22.00 Price Target at HC WainwrightMarketBeatNASDAQ:ERASRead Erasca (NASDAQ:ERAS) Given New $22.00 Price Target at HC Wainwright2 hours agoHC Wainwright Forecasts Strong Price Appreciation for Elemental Royalty (NASDAQ:ELE) StockMarketBeatNASDAQ:ELERead HC Wainwright Forecasts Strong Price Appreciation for Elemental Royalty (NASDAQ:ELE) Stock2 hours agoRobert W. Baird Forecasts Strong Price Appreciation for CoreWeave (NASDAQ:CRWV) StockMarketBeatNASDAQ:CRWVRead Robert W. Baird Forecasts Strong Price Appreciation for CoreWeave (NASDAQ:CRWV) Stock2 hours agoCoreWeave (NASDAQ:CRWV) Given New $176.00 Price Target at Cantor FitzgeraldMarketBeatNASDAQ:CRWVRead CoreWeave (NASDAQ:CRWV) Given New $176.00 Price Target at Cantor Fitzgerald2 hours agoCeragon Networks (NASDAQ:CRNT) Earns "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:CRNTRead Ceragon Networks (NASDAQ:CRNT) Earns "Buy" Rating from Needham & Company LLC2 hours agoChardan Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)MarketBeatNASDAQ:COYARead Chardan Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)2 hours agoCalumet (NASDAQ:CLMT) Given New $40.00 Price Target at TD CowenMarketBeatNASDAQ:CLMTRead Calumet (NASDAQ:CLMT) Given New $40.00 Price Target at TD Cowen2 hours agoHC Wainwright Issues Positive Forecast for Belite Bio (NASDAQ:BLTE) Stock PriceMarketBeatNASDAQ:BLTERead HC Wainwright Issues Positive Forecast for Belite Bio (NASDAQ:BLTE) Stock Price2 hours agoBicara Therapeutics (NASDAQ:BCAX) Stock Price Expected to Rise, BTIG Research Analyst SaysMarketBeatNASDAQ:BCAXRead Bicara Therapeutics (NASDAQ:BCAX) Stock Price Expected to Rise, BTIG Research Analyst Says2 hours agoAppLovin (NASDAQ:APP) Price Target Cut to $408.00 by Analysts at BTIG ResearchMarketBeatNASDAQ:APPRead AppLovin (NASDAQ:APP) Price Target Cut to $408.00 by Analysts at BTIG Research2 hours agoApogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by BTIG ResearchMarketBeatNASDAQ:APGERead Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by BTIG Research2 hours agoAffirm (NASDAQ:AFRM) Price Target Raised to $86.00 at BMO Capital MarketsMarketBeatNASDAQ:AFRMRead Affirm (NASDAQ:AFRM) Price Target Raised to $86.00 at BMO Capital Markets2 hours agoACADIA Pharmaceuticals (NASDAQ:ACAD) Given New $41.00 Price Target at Needham & Company LLCMarketBeatNASDAQ:ACADRead ACADIA Pharmaceuticals (NASDAQ:ACAD) Given New $41.00 Price Target at Needham & Company LLC2 hours agoBTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI)MarketBeatNASDAQ:ABSIRead BTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI)2 hours agoAbsci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:ABSIRead Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC2 hours agoVestis (NYSE:VSTS) Given New $16.00 Price Target at Robert W. BairdMarketBeatNYSE:VSTSRead Vestis (NYSE:VSTS) Given New $16.00 Price Target at Robert W. Baird2 hours agoUnited States Antimony (NYSE:UAMY) Price Target Lowered to $9.25 at HC WainwrightMarketBeatNYSE:UAMYRead United States Antimony (NYSE:UAMY) Price Target Lowered to $9.25 at HC Wainwright2 hours agoSimilarweb (NYSE:SMWB) Upgraded to Outperform at Northland SecuritiesMarketBeatNYSE:SMWBRead Similarweb (NYSE:SMWB) Upgraded to Outperform at Northland Securities2 hours agoSummit Midstream Partners (NYSE:SMC) Given New $43.00 Price Target at TD CowenMarketBeatNYSE:SMCRead Summit Midstream Partners (NYSE:SMC) Given New $43.00 Price Target at TD Cowen Featured Articles and OffersBank of America Corp DE Purchases 7,079,903 Shares of NIO Inc. $NIOBy MarketBeat | August 9, 2026The $15 Gold Fund That Pays Up to $1,152/MonthFrom Investors Alley (Ad)AMD’s Post-Earnings Drop May Be the Opportunity Investors WantedBy Thomas Hughes | August 5, 2026SoundHound AI Sends a Loud Signal After Its Q2 Earnings BeatBy Thomas Hughes | August 10, 2026Quantum Earnings Week: Winners and Losers Are Finally EmergingBy Nathan Reiff | August 8, 2026One trade you can make to move the needle todayFrom InvestorPlace (Ad)3 Stocks Whose Charts May Be Signaling the Next Big MoveBy Dan Schmidt | August 9, 20263 Stocks That Prove the AI Trade Isn't Over, It MovedBy Bridget Bennett | August 5, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 407 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
